Abstract
Objective: Polymorphism in the vitamin D receptor (VDR) gene has been associated with variation in bone mineral density and with prostate cancer risk. The purpose of this study was to determine whether polymorphism in the VDR gene may also influence breast cancer risk.
Methods: Polymorphisms in the 5′ and 3′ ends of the VDR gene were genotyped for 143 Latina women with breast cancer and 300 cohort controls.
Results: Both the BsmI and poly-A polymorphisms in the 3′ end of the VDR gene were associated with breast cancer risk, with a trend for increasing risk with increasing number of BsmI B alleles or short (S) poly-A alleles. Compared to subjects having two long poly-A alleles (genotype LL), odds ratios (and 95% confidence intervals) were 1.5 (1.0–2.3) and 3.2 (1.5–6.9) for subjects having genotypes SL and SS, respectively. Compared to BsmI genotype bb, odds ratios (and 95% confidence intervals) were 1.6 (1.1–2.5) and 2.2 (1.0–4.7) for genotypes Bb and BB respectively. The start codon polymorphism, FokI, was not associated with breast cancer risk.
Conclusion: These results suggest that polymorphic variation in or near the 3′ end of the VDR gene influences breast cancer risk in Latina women.
Similar content being viewed by others
References
Minghetti PP, Norman AW (1988) 1,25(OH)2-vitamin D3 recep-tors: gene regulation and genetic circuitry. FASEB J 2: 3043–3053.
Darwish H, DeLuca HF (1993) Vitamin D-regulated gene expres-sion. Crit Rev Eukaryot Gene Expr 3: 89–116.
Hannah SS, Norman AW (1994) 1a,25(OH)2 vitamin D-regulated expression of the eukaryotic genome. Nutr Rev 52: 376–382.
Saijo T, Ito M, Takeda E, et al. (1991) A unique mutation in the vitamin D receptor gene in three Japanese patients with vitamin D-dependent rickets type II: Utility of single-strand conformation polymorphism analysis for heterozygous carrier detection. Am JHum Genet 49: 668–673.
Miyamoto K, Kesterson RA, Yamamoto H, et al. (1997) Struc-tural organization of the human vitamin D receptor chromosomal gene and its promoter. Mol Endocrinol 11: 1165–1179.
Dawson-Hughes B, Harris SS, Finneran S (1995) Calcium absorp-tion on high and low calcium intakes in relation to vitamin D receptor genotype. J Clin Endocrinol Metab 80: 3657–3661.
Wishart JM, Horowitz M, Need AG, et al. (1997) Relations between calcium intake, calcitriol, polymorphisms of the vitamin D receptor gene, and calcium absorption in premenopausal women. Am J Clin Nutr 65: 798–802.
Morrison NA, Qi JC, Tokita A, et al. (1994) Prediction of bone density from vitamin D receptor alleles. Nature 367: 284–287.
Ma J, Stampfer MJ, Gann PH, et al. (1998) Vitamin D receptor polymorphisms, circulating vitamin D metabolites, and risk of prostate cancer in United States physicians. Cancer Epidemiol Biomarkers Prev 7: 385–390.
Morrison N (1998) Vitamin D receptor gene variants and osteoporosis: a contributor to the polygenic control of bone density. In: Feldman D, Glorieux FH, Pike JW, eds. Vitamin D. San Diego, CA: Academic Press, 713–732.
Taylor JA, Hirvonen A, Watson M, Pittman G, Mohler JL, Bell DA (1996) Association of prostate cancer with vitamin D receptor gene polymorphism. Cancer Res 56: 4108–4110.
Ingles SA, Ross RK, Yu MC, et al. (1997) Association of prostate cancer risk with genetic polymorphisms in vitamin D receptor and androgen receptor. J Natl Cancer Inst 89: 166–170.
Ingles SA, Coetzee GA, Ross RK, et al. (1998) Association of prostate cancer with vitamin D receptor haplotypes in African-Americans. Cancer Res 58: 1620–1623.
Berger U, Wilson P, McClelland RA, et al. (1988) Immunocyto-chemical detection of 1,25–dihydroxyvitamin D receptors in normal human tissues. J Clin Endocrinol Metab 67: 607–613.
Colston KW, Berger R, Coombes RC (1989) Possible role for vitamin D in controlling breast cancer cell proliferation. Lancet 1: 188–191.
Berger U, McClelland RA, Wilson P, et al. (1991) Immunocyto-chemical determination of estrogen receptor, progesterone recep-tor, and 1,25–dihydroxyvitamin D3 receptor in breast cancer and relationship to prognosis. Cancer Res 51: 239–244.
Ingles SA, Haile RW, Henderson BE, et al. (1997) Strength of linkage disequilibrium between two vitamin D receptor markers in five ethnic groups: implications for association studies. Cancer Epidemiol Biomarkers Prev 6: 93–98.
Reichardt JKV, Makridakis N, Henderson BE, Yu MC, Pike MC, Ross RK (1995) Genetic variability of the human SRD5A2 gene: implications for prostate cancer risk. Cancer Res 55: 3973–3975.
Monroe KR, Yu MC, Kolonel LN, et al. (1995) Evidence of an X-linked or recessive genetic component to prostate cancer risk. Nat Med I: 827–829.
Gross C, Eccleshall TR, Malloy PJ, Villa ML, Marcus R, Feldman D (1996) The presence of a polymorphism at the translation initiation site of the vitamin D receptor gene is associated with low bone mineral density in postmenopausal Mexican-American wom-en. J Bone Miner Res 11: 1850–1855.
Breslow NE, Day NE (1980) Statistical Methods in Cancer Research, vol. 1: The Analysis of Case-Control Studies. Lyon: IARC Scientific Publications.
Weir BS (1990) Genetic Data Analysis. Sunderland, MA: Sinauer Associates Inc.
McClure L, Eccleshall TR, Gross C, et al. (1997) Vitamin D receptor polymorphisms, bone mineral density, and bone metab-olism in postmenopausal Mexican-American women. J Bone Miner Res 12: 234–240.
Tokita A, Matsumoto H, Morrison NA, et al. (1996) Vitamin D receptor alleles, bone mineral density and turnover in premeno-pausal Japanese women. J Bone Miner Res 11: 1003–1009.
Eisman JA, Martin TJ, MacIntyre I, Moseley JM (1979) 1,25–dihydroxyvitamin-D receptor in breast cancer cells. Lancet 2: 1335–1336.
Frampton RJ, Omond SA, Eisman JA (1983) Inhibition of human cancer cell growth by 1,25–dihydroxyvitamin D3 metabolites. Cancer Res 43: 4443–4447.
Chouvet C, Vicard E, Devonecc M, Saez S (1986) 1,25–dihydroxy-vitamin D3 inhibitory effect on the growth of two human breast cancer cell lines (MCF-7, BT-20). J Steroid Biochem 24: 373–376.
Haussler CA, Marion SL, Pike JW, Haussler MR (1986) 1,25–dihydroxyvitamin D3 inhibits the clonogenic growth of trans-formed cells via its receptor. Biochem Biophys Res Commun 139: 136–143.
Frappart L, Falette N, Lefebvre MF, Bremond A, Vauzelle JL, Saez S (1989) In vitro study of e.ects of 1,25 dihydroxyvitamin D3 on the morphology of human breast cancer cell line BT.20. Differentiation 40: 63–69.
Abe J, Nakano T, Nishi Y, Matsumoto T, Ogaata E, Ikeda K (1991) A novel vitamin D3 analog, 22–oxa-1,25–dihydroxyvitamin D3, inhibits the growth of human breast cancer in vitro and in vivo without causing hypercalcemia. Endocrinology 129: 832–837.
Colston KW, Chander SK, MacKay AG, Coombes RC (1992) Effects of synthetic vitamin D analogues on breast cancer cell proliferation in vivo and in vitro. Biochem Pharmacol 44: 693–702.
Colston KW, Mackay AG, James SY, Binderup L, Chander S, Coommbes RC (1992) EB1089: a new vitamin D analogue that inhibits the growth of breast cancer cells in vivo and in vitro. Biochem Pharmacol 44: 2273–2280.
Mathiasen IS, Colston KW, Binderup L (1993) EB 1089, a novel vitamin D analogue, has strong antiproliferative and differentia-tion inducing effects on cancer cells. J Steroid Biochem Mol Biol 46: 365–371.
Oikawa T, Yoshida Y, Simamra M, et al. (1991) Antitumour effect of 22–oxa-1a-25–dihydroxyvitamin D3, a potent angiogenesis inhibitor of rat mammary tumours induced by 7,12–dimethy-benz[a]anthracene. Anticancer Drugs 2: 475–481.
Abe-Hashimoto J, Kikuchi T, Matsumoto T, Nishii Y, Ogata E, Ikeda K (1993) Antitumor effect of 22–oxa-calcitriol, a non-calcemic analogue of calcitriol, in athymic mice implanted with human breast carcinoma and its synergism with tamoxifen. Cancer Res 53: 2534–2537.
Anzano MA, Smith JM, Uskokovic MR, et al. (1994) 1alpha,25–dihydroxy-16–ene-23–yne-26,27–hexa¯uorocholecalciferol (Ro24–5531), a new deltanoid (Vitamin D analogue) for prevention of breast cancer in the rat. Cancer Res 54: 1653–1656.
Buras RR, Schumaker LM, Davoodi F, et al. (1994) Vitamin D receptors in breast cancer cells. Breast Cancer Res Treat 31: 191–202.
Carling T, Rastad J, AÉkerstroÉm G, Westin G (1998) Vitamin D receptor (VDR) and parathyroid hormone messenger ribonucleic acid levels correspond to polymorphic VDR alleles in human parathyroid tumors. J Clin Endocrinol Metab 83: 2255–2259.
Verbeek W, Gombart AF, Shiohara M, Campbell M, Koeffler HP (1997) Vitamin D receptor: no evidence for allele-specific mRNA stability in cells which are heterozygous for the TaqI restriction enzyme polymorphism. Biochem Biophys Res Commun 238: 77–80.
Mocharla H, Butch AW, Pappas AA, et al. (1997) Quantification of vitamin D receptor mRNA by competitive polymerase chain reaction in PBMC: lack of correspondence with common allelic variants. J Bone Miner Res 12: 726–733.
Gross C, Musiol IM, Eccleshall TR, Malloy PJ, Feldman D (1998) Vitamin D receptor gene polymorphisms: analysis of ligand binding and hormone responsiveness in cultured skin fibroblasts. Biochem Biophys Res Commun 242: 467–473.
Cooper GS, Umbach DM (1996) Are vitamin D receptor poly-morphisms associated with bone mineral density? A meta-analysis. J Bone Miner Res 11: 1841–1849.
Rozen F, Yang X-F, Huynh H, Pollak M (1997) Antiproliferative action of vitamin D-related compounds and insulin-like growth factor-binding protesin 5 accumulation. J Natl Cancer Inst 9: 652–656.
Colston KW, Perks CM, Xie SP, Holly JMP (1998) Growth inhibition of both MCF-7 and Hs578T human breast cancer cell lines by vitamin D analogues is associated with increased expres-sion of insulin-like growth factor binding protein-3. J Molec Endocrinol 20: 157–162.
Cauley JA, Lucas FL, Kuller LH, Vogt MT, Browner WS, Cummings SR (1996) Bone mineral density and risk of breast cancer in older women. The study of osteoporotic fractures. JAMA 276: 1404–1408.
Zhang Y, Kiel DP, Kreger BE, et al. (1997) Bone mass and the risk of breast cancer among postmenopausal women. N Engl J Med 336: 611–617.
Haussler MR, Whitfield GK, Haussler CA, et al. (1998) The nuclear vitamin D receptor: biological and molecular regulatory properties revealed. J Bone Miner Res 13: 325–349.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ingles, S.A., Garcia, D.G., Wang, W. et al. Vitamin D receptor genotype and breast cancer in Latinas (United States). Cancer Causes Control 11, 25–30 (2000). https://doi.org/10.1023/A:1008979417618
Issue Date:
DOI: https://doi.org/10.1023/A:1008979417618